Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 456,649 | 239,758 | 315,520 | 155,961 | 945 |
Receivables | 88 | 2,626 | 3,157 | 339 | N/A |
TOTAL | $466,395 | $248,385 | $320,188 | $156,840 | $968 |
Non-Current Assets | |||||
PPE Net | 18,500 | 18,857 | 21,027 | 1,328 | N/A |
Intangibles | 289 | 344 | 399 | 454 | 509 |
Other Non-Current Assets | 3,832 | 3,760 | 3,348 | 801 | 50 |
TOTAL | $22,621 | $22,961 | $24,774 | $2,583 | $559 |
Total Assets | $489,016 | $271,346 | $344,962 | $159,423 | $1,527 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 5,069 | 1,639 | 4,569 | 1,584 | 211 |
Accrued Expenses | 21,254 | 11,708 | 16,343 | 8,511 | 1,935 |
Other current liabilities | 1,321 | 1,164 | 1,086 | 60 | N/A |
TOTAL | $27,746 | $14,511 | $21,998 | $10,155 | $2,146 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | N/A | 38,336 | N/A |
Deferred Revenues | 102 | N/A | N/A | N/A | N/A |
Other Non-Current Liabilities | 11,295 | 12,075 | 12,497 | 770 | 621 |
TOTAL | $69,075 | $69,003 | $90,118 | $113,871 | $85 |
Total Liabilities | $96,821 | $83,514 | $112,116 | $124,026 | $2,231 |
Shareholders' Equity | |||||
Common Shares | 1,584 | 1,240 | 1,216 | 181 | 120 |
Retained earnings | -291,569 | -125,440 | -57,083 | -33,906 | -8,403 |
Other shareholders' equity | -65 | 14 | -26 | -35 | 6,411 |
TOTAL | $392,195 | $187,832 | $232,846 | $-29,124 | $-704 |
Total Liabilities And Equity | $489,016 | $271,346 | $344,962 | $94,902 | $1,527 |